Cargando…
BRAF V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancer
In stage IV colorectal cancer (CRC), initial resection of the primary tumor is considered to be an important strategy for improving disease outcome. However, there is no consensus on the timing as to when the surgical intervention of the primary tumor should occur. The present study hypothesizes tha...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776948/ https://www.ncbi.nlm.nih.gov/pubmed/29434925 http://dx.doi.org/10.3892/ol.2017.7553 |